RA: Does ultrasound help guide treat-to-target?
Targeting a DAS of less than 1.6 and no swollen joints is sufficient, researchers find
Ultrasound guidance does not improve the effectiveness of treat-to-target therapy in rheumatoid arthritis (RA), new findings confirm.
Norwegian researchers analysed data from the ARCTIC trial, on 218 participants who were randomised to a treat-to-target strategy aiming to keep the Disease Activity Score (DAS) below 1.6 and have no swollen joints either with or without the additional target of no power Doppler signal in any joint on ultrasound.
